Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci.
about
Genetic studies of rheumatoid arthritisIdentifying a novel locus for psoriatic arthritisRheumatoid arthritis susceptibility genes: An overviewPredictive factors of response to biological disease modifying antirheumatic drugs: towards personalized medicine.Early biomarkers of joint damage in rheumatoid and psoriatic arthritisGenome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritisGenetics and epigenetics of rheumatoid arthritisTYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traitsCD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritisLack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysisPharmacogenetics and pharmacogenomics in rheumatology.Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.Ultrasonographic assessment of enthesitis in HLA-B27 positive patients with rheumatoid arthritis, a matched case-only study.Lack of association of variants previously associated with anti-TNF medication response in rheumatoid arthritis patients: results from a homogeneous Greek populationHaptoglobin-α1, -α2, vitamin D-binding protein and apolipoprotein C-III as predictors of etanercept drug response in rheumatoid arthritis.Current and future trends in biomarker discovery and development of companion diagnostics for arthritis.Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only studyTNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis.Wnt signaling genes of murine chromosome 15 are involved in sex-affected pathways of inflammatory arthritis.Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial.Identification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment Response.Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort.The genetics of human autoimmune disease: A perspective on progress in the field and future directions.TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications?A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis.Genetics of rheumatoid arthritis - a comprehensive review.Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment responsePreviously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohort.Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study.A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy - results from a Swedish cohort study.TNF-α blockade induces IL-10 expression in human CD4+ T cells.Genetic and genomic predictors of anti-TNF response.Integrative genomics strategies to elucidate the complexity of drug response.Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis.Pharmacogenomics of biological treatment in rheumatoid arthritis.Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases.Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis.Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis.
P2860
Q26783892-04CB64E2-8DF2-463C-8E8A-CE462EC3BDC1Q26800688-3D854FCC-66D8-40B6-9F16-D299EC782A04Q26824670-00D50F08-D046-41D7-AC76-7E973C55305DQ27692641-79D0B081-1CAF-425B-B841-68AC872FC747Q28083506-AF10D8E1-01EC-4861-9002-CDB3A24A5C1CQ28489093-1B53771A-0FAA-4CB4-B28C-B519D24079D8Q28534348-C72F686F-C830-4C81-8A3A-B30908EC23B7Q28545832-CA9BC480-B78D-42D2-9149-E06AD3FE6BA8Q28728734-8B2D7397-87EE-46BC-A73E-93896B9928C8Q33766353-2E303197-3248-4D97-8D02-9949C51B9680Q34070615-EE2EAF6B-9569-46B4-88B4-FD16D8B2807DQ34216613-9ACF2CE0-F1F4-4A28-9BFE-61DEF0B42FC1Q34625960-B444969E-5D74-46E1-8566-ECC4F8DD599AQ34989977-7BD670B8-8938-4967-99E7-79E97EC6EB90Q35247643-3AE977DF-513A-4CF2-B94D-313DB8E9D7DCQ35470652-21B5D7A5-BD9A-4699-B076-074EF2570C18Q35544546-62EF0F55-A694-4F7D-8B0A-97BF4C6DC814Q35754087-66C97B2E-5D0F-4D7E-ADE0-1D25EBC1A22FQ35785711-2EF53384-E93B-4352-8E3B-80A5B4B748D1Q35792901-ED356493-AF4B-4F06-AD18-7AC8E90C4BEEQ36056195-70D8333F-FDA6-415A-B83A-A14659314661Q36189976-9B9BC576-27B0-4942-ABAA-8A6F8E5AA224Q36236745-4CC7A4AF-971F-4072-8687-FFFAA87983D5Q36361083-4DA7B0DD-8192-4673-8B5E-86E906AE2C6CQ36477515-6A281659-F940-4D9F-8835-D6724C056A00Q36847390-B2FDDB33-4CC0-4D87-AA8D-422799DE2265Q37054390-17325044-1C4E-41A4-8CD3-13F41C05CB9BQ37200651-88789452-AF5A-49C3-BA5B-99FA93AEAC53Q37256337-98560F29-C5D3-4D9E-9FC7-5C43454CA8BFQ37470261-28F50FA2-41A8-4195-8B32-673304E27BBAQ37570592-ADA2B4AE-FA36-4307-BC72-BA9488C32FDBQ37951648-B4A74B4F-985F-4B4E-97AE-51CFDF7C664CQ37961088-ED4F75D1-CC2F-4A14-95FE-18E1995C941FQ38084444-B3FBFB11-5C02-4BD3-B98B-2EC27D5BC32CQ38088942-A6C971EC-CE2E-4EDC-896D-5154C38F6230Q38167894-3D8ED33A-1CFC-4D52-8B51-FD2B847E8F85Q38286234-DEEB6A27-D84A-47C0-990B-4FBCF8334BC2Q38529234-02B3E013-CA3D-486B-AC11-D3B2D82C0D9DQ38728689-1D86B1E7-22BB-4F77-B4D8-485BB44B56B9Q38797638-505C3FB8-6B39-40D5-A96A-22B8B0E333F6
P2860
Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genome-wide association study ...... h polymorphisms at seven loci.
@ast
Genome-wide association study ...... h polymorphisms at seven loci.
@en
Genome-wide association study ...... h polymorphisms at seven loci.
@nl
type
label
Genome-wide association study ...... h polymorphisms at seven loci.
@ast
Genome-wide association study ...... h polymorphisms at seven loci.
@en
Genome-wide association study ...... h polymorphisms at seven loci.
@nl
prefLabel
Genome-wide association study ...... h polymorphisms at seven loci.
@ast
Genome-wide association study ...... h polymorphisms at seven loci.
@en
Genome-wide association study ...... h polymorphisms at seven loci.
@nl
P2093
P2860
P50
P356
P1476
Genome-wide association study ...... h polymorphisms at seven loci.
@en
P2093
Ann W Morgan
Anthony G Wilson
British Society for Rheumatology Biologics Register
Catherine Potter
Darren Plant
Kimme L Hyrich
P2860
P304
P356
10.1002/ART.30130
P577
2011-03-01T00:00:00Z